Safety and efficacy of rivaroxaban versus warfarin in atrial fibrillation with stage 4 to 5 chronic kidney disease including dialysis.

Res Pract Thromb Haemost · 2026 · PMC12992934 · PMID 41853584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although favorable trends were observed for ICH (27% reduction; HR, 0.73; 95% CI, 0.49-1.08) and GIB (32% reduction; HR, 0.68; 95% CI, 0.46-1.03), they did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.